Thermo Fisher Scientific Inc.
TMO
Below: live stock price for Thermo Fisher Scientific Inc. (TMO), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Thermo Fisher Scientific Inc. (TMO) is a Healthcare company based in United States. Operating in Diagnostics & Research, it employs about 125,000 people. Over the past year TMO traded between 435.27 and 704 USD. Trailing P/E sits near 37.14 on a market cap of about 255.13B USD. It currently yields 0.27% in dividends.
- Prev close
- $696.49
- Volume (24h)
- $1.45B
- Market cap
- $255.13B
- Currency
- USD
Score
49/ 100 · Mixed
- Value29
- Quality53
- Momentum51
- Growth42
- Risk82
- Dividend52
- Liquidity36
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 698.4993 +1.23%
- +20 bars
- 710.3985 +2.96%
- +60 bars
- 715.056 +3.63%
- +120 bars
- 715.2274 +3.66%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0238 USD.
Interpretation
Composite signals look mixed. Strength: risk profile with weakness: valuation. Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Value29/100
Value looks fragile — driven by P/E (37.14).
P/E:37.14P/B:4.84PEG:2.05 - Quality53/100
Quality looks mixed — driven by Gross margin (40.99%).
ROE:13.51%ROA:5.13%Profit margin:15.04%Gross margin:40.99% - Momentum51/100
Momentum looks mixed — driven by 52w change (26.88%).
52w change:26.88% - Growth42/100
Growth looks weak — driven by Revenue growth (10.50%).
Revenue growth:10.50%Earnings growth:9.40% - Risk82/100
Risk looks strong — driven by Debt / equity (80.58).
Beta:0.88Debt / equity:80.58Short interest:1.46% - Dividend52/100
Dividend looks mixed — driven by Payout ratio (9.69%).
Dividend yield:0.27%Payout ratio:9.69% - Liquidity36/100
Liquidity looks weak — driven by Current ratio (1.55).
Current ratio:1.55Quick ratio:1.01
Derived from public market data — informational, not investment advice.
Price report
How this asset has actually moved over the last 250 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 29.2%
- Max drawdown
- -31.5%
- Below period high
- -2.0%
- Best day
- +8.71%
- Worst day
- -9.20%
- Up days
- 51%
- Current streak
- 1 down
- Typical day swing
- 2.6%
- Volume vs average
- +32%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 704 high → 555.91 low · 60 bars
- ResistanceFib +161.8% extensionnot reached943.6097 USD+36.76% from current
- ResistanceFib +100% extensionnot reached852.09 USD+23.49% from current
- ResistanceFib +61.8% extensionnot reached795.5196 USD+15.29% from current
- ResistanceFib +27.2% extensionnot reached744.2805 USD+7.87% from current
- Current690 USD
- SupportFib 23.6% retracementNearesttested 9×669.0508 USD-3.04% from current
- SupportFib 38.2% retracementtested 4×647.4296 USD-6.17% from current
- SupportFib 50% midpointtested 7×629.955 USD-8.70% from current
- SupportFib 61.8% retracementtested 9×612.4804 USD-11.23% from current
- SupportFib 78.6% retracementtested 5×587.6012 USD-14.84% from current
- SupportFib −27.2% extensionnot reached515.6295 USD-25.27% from current
- SupportFib −61.8% extensionnot reached464.3903 USD-32.70% from current
- SupportFib −100% extensionnot reached407.8199 USD-40.90% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Financials
- 52w high
- $704.00
- 52w low
- $435.27
- 52w change
- 26.88%
- Day high
- $699.20
- Day low
- $683.63
- P/E (TTM)
- 37.14
- Forward P/E
- 25.01
- PEG
- 2.05
- Price / Book
- 4.84
- Beta (5Y)
- 0.88
- Enterprise value
- 293.74B
- EV / Revenue
- 6.34
- EV / EBITDA
- 25.02
- EPS (TTM)
- $18.58
- Forward EPS
- $27.58
- Dividend yield
- 0.27%
- Dividend rate
- $1.88
- Payout ratio
- 9.69%
- Revenue (TTM)
- 46.34B
- EBITDA
- 11.74B
- Free cash flow
- 6.24B
- Total cash
- 4.06B
- Total debt
- 42.55B
- Debt / Equity
- 80.58
- Current ratio
- 1.55
- Quick ratio
- 1.01
- Profit margin
- 15.04%
- Gross margin
- 40.99%
- Return on assets
- 5.13%
- Return on equity
- 13.51%
- Shares outstanding
- 369.75M
- Float
- 368.82M
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Analyst & Risk
- Beta (vs S&P 500)
- 0.88
- less volatile
- 52-week change
- 26.88%
- Short % of float
- 1.46%
- Short ratio (days)
- 2.46
- Debt / Equity
- 80.58
- very high leverage
- Current ratio
- 1.55
- Quick ratio
- 1.01
- ROE
- 13.51%
- ROA
- 5.13%
- PEG ratio
- 2.05
- richly valued
- EV / Revenue
- 6.34
- EV / EBITDA
- 25.02
- Revenue growth
- 10.50%
- Earnings growth
- 9.40%
- EBITDA
- 11.74B
- Free cash flow
- 6.24B
- Total cash
- 4.06B
- Total debt
- 42.55B
- Insider holdings
- 0.13%
- Institutional
- 93.98%
Recent rating changes
- 2026-10-13Morgan StanleyOverweight → Overweightmain
- 2026-10-13TD CowenBuy → Buymain
- 2026-10-07BarclaysOverweight → Overweightmain
- 2026-09-03CLSAOutperforminit
- 2026-07-27Piper SandlerNeutral → Neutralmain
- 2026-07-27Morgan StanleyOverweight → Overweightmain
- 2026-07-24RBC CapitalSector Perform → Sector Performmain
- 2026-07-24BarclaysOverweight → Overweightmain
Financial documents
- Periodic Financial Reports10-Q2026-07-31
- Corporate Changes & Voting Matters8-K2026-07-23
- Annual report of employee stock purchase11-K2026-06-23
- Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)SD2026-05-28
- Corporate Changes & Voting Matters8-K2026-05-26
- Proxy StatementsDEFA14A2026-05-11
- Periodic Financial Reports10-Q2026-05-01
- Corporate Changes & Voting Matters8-K2026-04-23
- Proxy StatementsDEF 14A2026-04-07
- Corporate Changes & Voting Matters8-K2026-03-24
- Periodic Financial Reports10-K2026-02-26
- Corporate Changes & Voting Matters8-K2026-02-12
Recent news
- Thermo Fisher Scientific (TMO) Is Building A Bigger Role In Precision DiagnosticsSimply Wall St.1d ago
- Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target IncreasesSimply Wall St.2d ago
- Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip StocksBarrons.com2d ago
- Learn Why The Bull Case For Thermo Fisher Scientific Stock Could Change Following Omics Demand GrowthSimply Wall St.2d ago
- Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences RecoveryInsider Monkey2d ago
- Academic and Government Spending Powers Thermo Fisher (TMO)Insider Monkey2d ago
- What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 EarningsZacks2d ago
- If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth NowZacks2d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,431 USD-1.27%
- 7203.TToyota Motor Corporation3,075 USD-0.61%
- 9984.TSoftBank Group Corp.4,732 USD-4.29%
- 6758.TSony Group Corporation3,946 USD-0.33%
- 6861.TKeyence Corporation79,950 USD-1.00%
- NVDANVIDIA Corporation214.13 USD-1.43%
- AAPLApple Inc.343.46 USD+0.43%
- GOOGLAlphabet Inc.340.59 USD-2.47%
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.